Liao Z - Search Results

1

A single-cell analysis reveals tumor heterogeneity and immune environment of acral melanoma.

Zhang C, Shen H, Yang T, Li T, Liu X, Wang J, Liao Z, Wei J, Lu J, Liu H, Xiang L, Yang Y, Yang M, Wang D, Li Y, Xing R, Teng S, Zhao J, Yang Y, Zhao G, Chen K, Li X, Yang J. Zhang C, et al. Among authors: liao z. Nat Commun. 2022 Nov 25;13(1):7250. doi: 10.1038/s41467-022-34877-3. Nat Commun. 2022. PMID: 36433984 Free PMC article.

2

Correlation of WWOX, RUNX2 and VEGFA protein expression in human osteosarcoma.

Yang J, Zhao L, Tian W, Liao Z, Zheng H, Wang G, Chen K. Yang J, et al. Among authors: liao z. BMC Med Genomics. 2013 Dec 15;6:56. doi: 10.1186/1755-8794-6-56. BMC Med Genomics. 2013. PMID: 24330824 Free PMC article.

3

Roles of low-density lipoprotein receptor-related protein 1 in tumors.

Xing P, Liao Z, Ren Z, Zhao J, Song F, Wang G, Chen K, Yang J. Xing P, et al. Among authors: liao z. Chin J Cancer. 2016 Jan 6;35:6. doi: 10.1186/s40880-015-0064-0. Chin J Cancer. 2016. PMID: 26738504 Free PMC article. Review.

4

Recombined humanized endostatin (Endostar) combined with chemotherapy for advanced bone and soft tissue sarcomas in stage IV.

Xing P, Zhang J, Yan Z, Zhao G, Li X, Wang G, Yang Y, Zhao J, Xing R, Teng S, Ma Y, Liao Z, Ren Z, Zhang C, Han X, Zhang W, Chen K, Wang P, Yang J. Xing P, et al. Among authors: liao z. Oncotarget. 2017 May 30;8(22):36716-36727. doi: 10.18632/oncotarget.13545. Oncotarget. 2017. PMID: 27888623 Free PMC article.

5

Recent translational research into targeted therapy for liposarcoma.

Patel RB, Li T, Liao Z, Jaldeepbhai JA, Perera HAPNV, Muthukuda SK, Dhirubhai DH, Singh V, Du X, Yang J. Patel RB, et al. Among authors: liao z. Stem Cell Investig. 2017 Mar 15;4:21. doi: 10.21037/sci.2017.02.09. eCollection 2017. Stem Cell Investig. 2017. PMID: 28447036 Free PMC article. Review.

6

Efficacy and safety of Apatinib in stage IV sarcomas: experience of a major sarcoma center in China.

Li F, Liao Z, Zhao J, Zhao G, Li X, Du X, Yang Y, Yang J. Li F, et al. Among authors: liao z. Oncotarget. 2017 Mar 16;8(38):64471-64480. doi: 10.18632/oncotarget.16293. eCollection 2017 Sep 8. Oncotarget. 2017. PMID: 28969086 Free PMC article.

7

Downregulation of lncRNA H19 inhibits the migration and invasion of melanoma cells by inactivating the NF‑κB and PI3K/Akt signaling pathways.

Liao Z, Zhao J, Yang Y. Liao Z, et al. Mol Med Rep. 2018 May;17(5):7313-7318. doi: 10.3892/mmr.2018.8782. Epub 2018 Mar 20. Mol Med Rep. 2018. PMID: 29568965

8

Apatinib as targeted therapy for sarcoma.

Li F, Liao Z, Zhang C, Zhao J, Xing R, Teng S, Zhang J, Yang Y, Yang J. Li F, et al. Among authors: liao z. Oncotarget. 2018 May 11;9(36):24548-24560. doi: 10.18632/oncotarget.24647. eCollection 2018 May 11. Oncotarget. 2018. PMID: 29849960 Free PMC article. Review.

9

Phase II trial of VEGFR2 inhibitor apatinib for metastatic sarcoma: focus on efficacy and safety.

Liao Z, Li F, Zhang C, Zhu L, Shi Y, Zhao G, Bai X, Hassan S, Liu X, Li T, Xing P, Zhao J, Zhang J, Xing R, Teng S, Yang Y, Chen K, Yang J. Liao Z, et al. Exp Mol Med. 2019 Feb 28;51(3):1-11. doi: 10.1038/s12276-019-0221-7. Exp Mol Med. 2019. PMID: 30816108 Free PMC article. Clinical Trial.

10

Outcomes of surgery and/or combination chemotherapy for extraskeletal osteosarcoma: a single-center retrospective study from China.

Liao Z, Qiu M, Yang J, Yang Y, Zhu L, Yang B, Bai X, Xing P, Zhang J, Xing R, Teng S, Zhao J. Liao Z, et al. Sci Rep. 2019 Mar 18;9(1):4816. doi: 10.1038/s41598-019-41089-1. Sci Rep. 2019. PMID: 30886189 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,334 results

Search Page